⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ARGX News
argenx SE American Depositary Shares
argenx Announces FDA Acceptance of Supplemental Biologics License Application with Priority Review for VYVGART in AChR-Ab Seronegative gMG
globenewswire.com
ARGX
argenx Highlights 2026 Strategic Priorities
globenewswire.com
ARGX
argenx to Present at 44th Annual J.P. Morgan Healthcare Conference
globenewswire.com
ARGX
John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), to Deliver Keynote Address on the Future of Biotech and Rare Disease Innovation at the 2026 MDA Clinical & Scientific Conference
globenewswire.com
AMGN
REGN
GILD
BMY
AZN
NVS
ARGX
BIIB
BBIO
SRRK
argenx Announces Results of Extraordinary General Meeting of Shareholders
globenewswire.com
ARGX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of argenx SE - ARGX
prnewswire.com
ARGX